Tag: VIVA 2017

Merging the portfolios and strengths of Philips and Spectranetics

At the recent Vascular Interventional Advances 2017 conference (VIVA; 11–14 September, Las Vegas, USA), Vascular News caught up with Philips' Atul Gupta (Global Chief...

Serranator Alto serration balloon effective at 30 days in treating critical...

Preliminary 30-day data from the PRELUDE trial investigating the use of the Serranator Alto percutaneous transluminal angioplasty (PTA) serration balloon catheter (Cagent Vascular) have...

ACT 1 subgroup analysis shows benefit of carotid artery stenting for...

New ACT 1 subgroup analysis demonstrates that in female patients the rate of ipsilateral stroke is lower with carotid artery stenting (CAS) compared with...

Encouraging 100% primary patency and improved quality-of-life scores at six months...

Data from the Surmodics PREVEIL early feasibility study of the company’s SurVeil drug-coated balloon (DCB) was shared in a late-breaking clinical trial presentation at...